Local paclitaxel delivery for the prevention of restenosis: biological effects and efficacy in vivo

Schiff, 1979, Promotion of microtubule assembly in vitro by taxol, Nature, 277, 665, 10.1038/277665a0 Schneider B. Taxol. Ein Arzneistoff aus der Rinde der Eibe. Deutsche Apotheker Zeitung 1996;134:19–30. Rowinsky, 1995, Paclitaxel (Taxol), N Engl J Med, 332, 1004, 10.1056/NEJM199504133321507 Straubinger, 1993, Novel taxol formulations, Monogr Natl Cancer Inst, 15, 69 Jordan, 1993, Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations, Proc Natl Acad Sci USA, 90, 9552, 10.1073/pnas.90.20.9552 Axel, 1997, Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery, Circulation, 96, 636, 10.1161/01.CIR.96.2.636 Sollot, 1995, Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat, J Clin Invest, 95, 1869, 10.1172/JCI117867 Sauro MD, Camporesi DA, Sudakow RL. The anti-tumor agent, taxol, attenuates contractile activity in rat aortic smooth muscle. Life Sciences 1996;56:PL157–61. Hanke, 1990, Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty, Circ Res, 67, 651, 10.1161/01.RES.67.3.651 Hanke, 1991, Morphological changes and smooth muscle cell proliferation after experimental excimer laser treatment, Circulation, 83, 1380, 10.1161/01.CIR.83.4.1380 Betz, 1979, Responses of vessel walls to chronically applied electric stimuli, Basic Res Cardiol, 74, 10, 10.1007/BF01907681 Tsukada, 1986, Immunocytochemicel analysis of cellular components in atherosclerotic lesions, Arteriosclerosis, 6, 601, 10.1161/01.ATV.6.6.601 Gabbiani, 1984, Actin expression in smooth muscle cells of rat aortic intimal thickening, human atheromatous plaque, and cultured rat aortic media, J Clin Invest, 74, 148, 10.1172/JCI111185 Dartsch, 1994, Cytoskeletal reorganization in NIH 3T3 fibroblasts expressing the ras oncogene, Eur J Cell Biol, 63, 316 Dartsch, 1990, Growth characterisitics and cytoskeletal organization of cultured smooth muscle cells from human primary stenosing and restenosing lesions, Arteriosclerosis, 10, 62, 10.1161/01.ATV.10.1.62 Heinle, 1984, Vasoconstriction of carotid artery induced by hydroperoxides, Arch Int Physiol Biochem, 92, 267, 10.3109/13813458409071166 Baumbach, 1995, Vascular contractile function following experimental excimer laser angioplasty, Lasers Med Sci, 10, 25, 10.1007/BF02133160 Lincoff, 1994, Local drug delivery for the prevention of restenosis. Fact, fancy and future, Circulation, 90, 2070, 10.1161/01.CIR.90.4.2070 O’Keefe, 1992, Ineffectiveness of colchicine for the prevention of restenosis after coronary angioplasty, J Am Coll Cardiol, 19, 1597, 10.1016/0735-1097(92)90624-V Muller, 1992, Intramural methotrexate therapy for the prevention of neointimal thickening after balloon angioplasty, J Am Coll Cardiol, 20, 460, 10.1016/0735-1097(92)90118-7 Wani, 1971, Plant antitumor agents, VI, J Am Chem Soc, 93, 2325, 10.1021/ja00738a045 Nishio, 1995, Enhanced interactions between tubulin and microtubule-associated protein 2 via inhibition of MAP kinase and CDC2 kinase by paclitaxel, Int J Cancer, 63, 688, 10.1002/ijc.2910630514 Ding, 1993, Taxol shares the ability of bacterial lipopolysaccharide to induce tyrosine phosphorylation of microtubule-associated protein kinase, J Immunol, 151, 5596, 10.4049/jimmunol.151.10.5596 Rosette, 1995, Cytoskeletal control of gene expression, Circulation, 86, 100 Rowinsky, 1991, Cardiac disturbances during the administration of taxol, J Clin Oncol, 9, 1704, 10.1200/JCO.1991.9.9.1704 Rowinsky, 1993, Clinical toxicities encountered with paclitaxel (Taxol), Semin Oncol, 20, 1 Leu, 1993, Characterization of polyclonal and monoclonal anti-taxol antibodies and measurement of taxol in serum, Cancer Res, 53, 1388 Wilensky, 1991, Direct intraarterial wall injection of microparticles via a catheter, Am Heart J, 122, 1136, 10.1016/0002-8703(91)90482-W Lambert, 1993, Local drug delivery catheters, Coron Artery Dis, 4, 469, 10.1097/00019501-199305000-00011 Wilensky, 1995, Regional and arterial localization of radioactive microparticles after local delivery by unsupported or supported porous balloon catheters, Am Heart J, 129, 852, 10.1016/0002-8703(95)90103-5 Fram, 1994, Localized intramural drug delivery during balloon angioplasty using hydrogel-coated balloons and pressure-augmented diffusion, J Am Coll Cardiol, 23, 1570, 10.1016/0735-1097(94)90658-0 Oberhoff, 1997, Time course of smooth muscle cell proliferation after local drug delivery of low molecular weight heparin using a porous balloon catheter, Cathet Cardiovasc Diagn, 41, 268, 10.1002/(SICI)1097-0304(199707)41:3<268::AID-CCD7>3.0.CO;2-4 Camenzind, 1997, Site-specific intracoronary heparin delivery in humans after balloon angioplasty. A radioisotopic assessment of regional pharmacokinetics, Circulation, 96, 154, 10.1161/01.CIR.96.1.154 Horwitz, 1986, Taxol, Ann NY Acad Sci, 466, 733, 10.1111/j.1749-6632.1986.tb38455.x De Brabander, 1981, Taxol induces the assembly of free microtubules in living cells and blocks the organizing capacity of the centrosomes and kinetochores, Proc Natl Acad Sci USA, 78, 5608, 10.1073/pnas.78.9.5608 Stary, 1992, A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the committee on vascular lesions of the Council on Arteriosclerosis, American Heart Association, Circulation, 85, 391, 10.1161/01.CIR.85.1.391 Mintz, 1996, Arterial remodeling after coronary angioplasty. A serial intravascular ultrasound study, Circulation, 94, 35, 10.1161/01.CIR.94.1.35 Herdeg, 1997, Local drug delivery with porous balloons in the rabbit, Cathet Cardiovasc Diagn, 41, 308, 10.1002/(SICI)1097-0304(199707)41:3<308::AID-CCD12>3.0.CO;2-J